English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A 76-year-old woman presented with life-limiting claudication in the left leg. Ankle brachial index (ABI) was 1.07/0.63 (right/left). Duplex ultrasound showed a decreased flow pattern of the left popliteal artery with normal flow pattern in the common femoral artery (CFA), and stenosis or occlusion of the left SFA was strongly suspected. Angiography 1 month later showed severe stenosis in the olymer-free, paclitaxel-coated nitinol drug-eluting stent (Zilver PTX; Cook Medical, Bloomington, IN, USA) is now available for the treatment of peripheral artery disease in the superficial femoral artery (SFA), and durable clinical outcomes compared to the bare-metal stent counterpart have been reported.1–4 Arterial repair after Zilver PTX implantation in the SFA, however, remains uncharacterized. P

Two-Month Angioscopic Evaluation of Superficial Femoral Artery Treated With Paclitaxel-Coated Nitinol Drug-Eluting Stent